August 1, 2024

ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading&nbsp ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading 

by

ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading&nbsp ydus has received marketing approval from Mexican regulatory authority COFEPRIS for Mamitra, a Trastuzumab biosimilar. #FinancialNews #Trading 

Please follow and like us:
fb-share-icon
Tweet
Pin Share

Related posts:

No related posts.

Tags:

Comments are closed.

You may also like

August 28, 2024
by

Pharma Shares are in Focus Today Healthy Volume and Price Gains Signalling Rally in CIPLA, DIVIS LAB, AUROBINDO PHARMA,LUPON #Investment #StockMarket #FinancialNews #TradingGlobal https://sharelic.in Pharma Shares are in Focus Today Healthy Volume and Price Gains Signalling Rally in CIPLA, DIVIS LAB, AUROBINDO PHARMA,LUPON #Investment #StockMarket #FinancialNews #TradingGlobal https://sharelic.in

Pharma Shares are in Focus Today Healthy Volume and Price Gains Signalling Rally in CIPLA, DIVIS LAB, AUROBINDO PHARMA,LUPON #Investment...